Lupin Gets USFDA Nod for Generic Eye Medication
Lupin receives USFDA approval to market a generic medication for swelling and pain in the eye, a generic equivalent of Sun Pharma's BromSite Ophthalmic Solution.
New Delhi, Feb 6 (PTI) Drug maker Lupin on Tuesday said it has received approval from the US health regulator to market a generic medication to treat swelling and pain in the eye.
The company has received approval from the US Food and Drug Administration (USFDA) for Bromfenac Ophthalmic Solution, the Mumbai-based drug maker said in a statement.
The company's product is the generic equivalent of Sun Pharma's BromSite Ophthalmic Solution, it added.
Lupin is the exclusive first-to-file for this product, the drug maker said.
Shares of Lupin ended 0.43 per cent higher at Rs 1,579.75 apiece on the BSE.
The company has received approval from the US Food and Drug Administration (USFDA) for Bromfenac Ophthalmic Solution, the Mumbai-based drug maker said in a statement.
The company's product is the generic equivalent of Sun Pharma's BromSite Ophthalmic Solution, it added.
Lupin is the exclusive first-to-file for this product, the drug maker said.
Shares of Lupin ended 0.43 per cent higher at Rs 1,579.75 apiece on the BSE.
You May Like To Read
TODAY'S MOST TRADED COMPANIES
- Company Name
- Price
- Volume
- Vodafone Idea L
- 7.32 (+ 0.69)
- 51391136
- Sharanam Infra
- 0.61 (+ 3.39)
- 17951020
- GTL Infrastructure
- 1.49 ( 0.00)
- 17675604
- Vikas Lifecare
- 2.60 ( -9.41)
- 17580849
- YES Bank Ltd.
- 18.09 (+ 1.23)
- 11801097
MORE NEWS
© 2025 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback